Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Arbutus Biopharma Cp

TRADE

NASDAQ: ABUSHealthcare / Biotechnology / Canada
11.55+0.15+1.32%Vol 489 2791Y Perf 202.63%
Jul 20th, 2018 16:00
BID11.00 ASK12.00
Open11.50 Previous Close11.40
Pre-Market11.55 After-Trading11.55
 0.15 1.32%  - -%
Target Price
8.67 
Analyst Rating
Moderate Buy 2.00
Potencial %
-24.94 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
+     30.79
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)637 
Earnings Rating
Sell
Price Range Ratio 52wk %
94.35 
Earnings Date
2nd Aug 2018

Today's Price Range

11.3512.00

 

52wk Range

3.2012.05

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
81.03%
3 Months
111.93%
6 Months
122.12%
1 Year
202.63%
3 Years
6.65%
5 Years
123.84%

Quotes

Name / TickerPriceChg.Chg.%
ABUS11.550.15001.32
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 16.70
Current Ratio 16.90
Long Term Debt to Total Capital 0.06
Total Debt to Equity 0.09
Interest Coverage -334.00
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-427.30
EBIT Margin-900.90
EBITDA Margin-881.60
Pre-tax Profit Margin-6 902.50
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 5.66
PS Ratios 362.21
Price to Cash Flow 7 665.10
Price to Free Cash Flow -13.70
Cash Flow Per Share -0.93
Price to Tangible Book20.80
Book Value per Share2.07
Enterprise Value (in ths.)597 157
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-60.49
ROE last 12 Months -51.95
Return on Assets (5Y Avg) -45.45
ROA last 12 Months -29.80
Return on Capital (5Y Avg) -50.09
ROC last 12 Months -58.10
Return on invested Capital Q -16.55
Return on invested Capital Y-47.99
Assets Turnover0.00
Receivables Turnover1.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)1 782
Revenue per Share 0.03
Revenue Growth 3 Years -32.08
Revenue Growth 5 Years -18.87
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.38-0.365.26
Q04 2017-0.39-0.90-130.77
Q03 2017-0.38-0.1755.26
Q02 2017-0.35-0.2820.00
Q01 2017-0.30-0.34-13.33
Q04 2016-0.38-0.380.00
Q03 2016-0.53-0.3141.51
Q02 2016-0.35-0.350.00
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.35-6.06Negative
9/2018 QR-0.33-3.13Negative
12/2018 FY-1.49-4.93Negative
12/2019 FY-1.54-18.46Negative
Next Report Date2nd Aug 2018
Estimated EPS Next Report-0.35
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume489 279
Shares Outstanding (in ths.)55 170
Trades Count2 283
Dollar Volume5 314 494
Avg. Volume277 328
Avg. Weekly Volume509 741
Avg. Monthly Volume855 600
Avg. Quarterly Volume399 165

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

77%23%

Bearish Bullish

78%22%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (50.00 %)
1 (25.00 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Strong Buy
1.50
Strong Buy
1.50

There are no comments yet.

News

x